Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

The aim of this study was to evaluate the efficacy and toxicity of a concurrent chemoradiotherapy using docetaxel, cisplatin and 5-fluorouracil (5-FU) (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). In total, 19 patients with previously untreated stage I...

Descripción completa

Detalles Bibliográficos
Autores principales: Katori, H, Tsukuda, M, Mochimatu, I, Ishitoya, J, Kawai, S, Mikami, Y, Matsuda, H, Tanigaki, Y, Horiuchi, C, Ikeda, Y, Taguchi, T, Ono, M, Yoshida, T, Hirose, S, Sakuma, Y, Yamamoto, K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409561/
https://www.ncbi.nlm.nih.gov/pubmed/14735175
http://dx.doi.org/10.1038/sj.bjc.6601471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409561/
https://www.ncbi.nlm.nih.gov/pubmed/14735175
http://dx.doi.org/10.1038/sj.bjc.6601471

Ejemplares similares